LEVIN MARK J
Related Filers (36)
- TEPPER ROBERT I (84)
- MILLENNIUM PHARMACEUTICALS INC (68)
- STARR KEVIN P (65)
- Third Rock Ventures GP II, L.P. (50)
- Third Rock Ventures II, L.P. (50)
- TRV GP II, LLC (50)
- TRV GP III, LLC (31)
- Third Rock Ventures GP III, L.P. (31)
- Third Rock Ventures III, L.P. (31)
- Third Rock Ventures GP, L.P. (21)
- THIRD ROCK VENTURES LP (21)
- TRV GP, LLC (21)
- MyoKardia Inc (12)
- Voyager Therapeutics, Inc. (12)
- Jounce Therapeutics, Inc. (11)
- Global Blood Therapeutics, Inc. (10)
- Sage Therapeutics, Inc. (9)
- Blueprint Medicines Corp (7)
- CytomX Therapeutics, Inc. (7)
- Revolution Medicines, Inc. (7)
- TRV GP IV, LLC (6)
- Third Rock Ventures GP IV, L.P. (6)
- Third Rock Ventures IV, L.P. (6)
- Fulcrum Therapeutics, Inc. (6)
- Foundation Medicine, Inc. (5)
- ZAFGEN, INC. (5)
- Nurix Therapeutics, Inc. (4)
- Relay Therapeutics, Inc. (4)
- Eleven Biotherapeutics, Inc. (3)
- Editas Medicine, Inc. (3)
- CONSTELLATION PHARMACEUTICALS INC (3)
- RHYTHM PHARMACEUTICALS, INC. (3)
- Allena Pharmaceuticals, Inc. (2)
- Neon Therapeutics, Inc. (2)
- PLIANT THERAPEUTICS, INC. (2)
- Decibel Therapeutics, Inc. (1)
- Show More ...
Other (19)
13F-NT
Friday, 8/12/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/10/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 11/5/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 8/11/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 5/12/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 11/6/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/7/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/11/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/5/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/4/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/6/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/3/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 1/28/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 10/29/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/7/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 4/19/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/13/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (186)
4
Tuesday, 11/16/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/12/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/11/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/7/2021
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/10/2021
Nurix Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/15/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/3/2021
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/26/2021
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 2/12/2021
Decibel Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 2/8/2021
Nurix Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 1/14/2021
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/14/2021
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/23/2020
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/11/2020
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/29/2020
Nurix Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Nurix Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/21/2020
Relay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/15/2020
Relay Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/15/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/9/2020
PLIANT THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/2/2020
PLIANT THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/18/2020
Revolution Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/12/2020
Revolution Medicines, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/22/2019
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/17/2019
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/19/2018
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/4/2018
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 8/24/2018
CONSTELLATION PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/24/2018
CONSTELLATION PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/18/2018
CONSTELLATION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Tuesday, 7/3/2018
Neon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/26/2018
Neon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/21/2018
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/18/2018
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/7/2018
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 2/13/2018
MyoKardia Inc: Statement of changes in beneficial ownership of securities
5
Tuesday, 2/13/2018
MyoKardia Inc: Annual statement of changes in beneficial ownership of securities
4
Friday, 1/5/2018
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Friday, 12/8/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Monday, 11/6/2017
Allena Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/1/2017
Allena Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/19/2017
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/11/2017
RHYTHM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/4/2017
RHYTHM PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 9/29/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/27/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/12/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 7/13/2017
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/30/2017
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2017
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/19/2017
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/14/2017
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2017
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Monday, 3/27/2017
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/20/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2017
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2017
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/28/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 2/9/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2017
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/26/2017
Jounce Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 12/21/2016
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2016
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/1/2016
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/16/2016
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/9/2016
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/7/2016
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/19/2016
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2016
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2016
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/15/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 2/8/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/2/2016
Editas Medicine, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 11/18/2015
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/18/2015
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2015
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/10/2015
Voyager Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/5/2015
MyoKardia Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/28/2015
MyoKardia Inc: Initial statement of beneficial ownership of securities
4
Friday, 10/23/2015
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/8/2015
CytomX Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/19/2015
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2015
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/18/2015
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/11/2015
Global Blood Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/24/2015
ZAFGEN, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/22/2015
Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities